News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Dana-Farber Cancer Institute
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Hormone Therapy For Prostate Cancer Patients With Heart Conditions Linked To Increased Death Risk, Brigham and Women’s Hospital And Dana-Farber Cancer Institute Study
August 27, 2009
·
1 min read
Genetown
Hormone Drugs Dangerous For Some Prostate Patients, Brigham and Women’s Hospital And Dana-Farber Cancer Institute Study
August 26, 2009
·
1 min read
Genetown
Combined Transplant-Vaccine Therapy For High-risk Leukemia Shows Promise, Dana-Farber Cancer Institute Study
August 25, 2009
·
1 min read
Genetown
Dana-Farber Cancer Institute Study Supports DNA Repair-blocker Research In Cancer Therapy
August 20, 2009
·
1 min read
Genetown
Aspirin Seen Aiding Colorectal Cancer Patients, Massachusetts General Hospital, Dana-Farber Cancer Institute And Brigham and Women’s Hospital Study
August 12, 2009
·
1 min read
Genetown
Discovery May Help Treat Obesity, Dana-Farber Cancer Institute Study
July 30, 2009
·
1 min read
Gene Test May Predict Prostate Cancer, Dana-Farber Cancer Institute Study
June 3, 2009
·
1 min read
BioMidwest
Chemotherapy Combination Outcomes Differ For Aged, Younger Colon Cancer Patients, Dana-Farber Cancer Institute And Mayo Clinic Study
May 29, 2009
·
1 min read
Genetown
New Blood Test Greatly Reduces False-positives In Prostate Cancer Screening, Dana-Farber Cancer Institute Study
May 29, 2009
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
March 9, 2026
·
6 min read
Press Releases
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
March 4, 2026
·
13 min read
Press Releases
TAG1 Announces Strategic Collaboration to Advance Targeted Alpha Therapies
March 2, 2026
·
3 min read
Press Releases
CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting
February 20, 2026
·
15 min read
Press Releases
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
January 23, 2026
·
4 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
·
19 min read
Press Releases
ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
December 16, 2025
·
19 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
Press Releases
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
December 2, 2025
·
4 min read
Press Releases
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
November 20, 2025
·
4 min read
